Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -25.98
- Piotroski Score 2.00
- Grade Buy
- Symbol (RKDA)
- Company Arcadia Biosciences, Inc.
- Price $2.72
- Changes Percentage (2.45%)
- Change $0.07
- Day Low $2.68
- Day High $2.72
- Year High $5.34
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 03/26/2025
- Fiscal Year End N/A
- Average Stock Price Target $6.00
- High Stock Price Target $6.00
- Low Stock Price Target $6.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$1.77
- Trailing P/E Ratio -1.66
- Forward P/E Ratio -1.66
- P/E Growth -1.66
- Net Income $-13,981,000
Income Statement
Quarterly
Annual
Latest News of RKDA
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Arcadia Biosciences Inc (RKDA) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...
The $150,000 write-down in the financial results was related to both hemp and GoodWheat seed and occurred in this quarter. Excluding this and other specific items, margins are around 33%, aligning wit...
By Yahoo! Finance | 1 week ago -
Polen Capital Focus Growth Strategy Increased its Position in Workday (WDAY) Amid a Pullback
Polen Capital released its Q3 2024 investor letter for the "Polen Focus Growth Strategy" noting a 3.21% return. Highlighting Workday, Inc. as a key stock pick, the letter praises its growth potential ...
By Yahoo! Finance | 1 week ago -
A 72-year-old VC who started running at 54 does 4 marathons a year. Here's how he fits running into his busy workday.
Greg Ho, a 72-year-old New York investment firm president, transformed his health by running marathons after struggles fitting exercise into his routine. Despite ankle and leg issues, he aims to compl...
By Business Insider | 2 weeks ago
